Prenatal cocaine exposure remains a major public health concern because of its adverse effects on cognitive function. Although the molecular mechanisms underlying the cognitive impairment are not fully understood, brain-derived neurotrophic factor (BDNF) signaling via its receptor tyrosine kinase B (TrkB) is emerging as a potential candidate. We used a mouse model to examine the impact of ongoing cocaine exposure on BDNF expression in the dorsal forebrain on embryonic day 15 (E15) as well as the long-term effects of prenatal cocaine exposure on BDNF-TrkB signaling in the frontal cortex in early postnatal (postnatal day 16; P16) and adult (P60) male and female mice. We found that ongoing cocaine exposure decreased BDNF expression in the E15 dorsal forebrain, prenatal cocaine exposure did not alter BDNF or TrkB (total or phosphorylated) expression in the frontal cortex at P16, and that the prenatal cocaine exposure produced significant increases in BDNF, the activated (phosphorylated) form of TrkB, as well as Bdnf mRNA in the frontal cortex at P60. The increase in BDNF protein and mRNA expression at P60 was concurrent with hyperacetylation of histone H3 at the Bdnf promoter in the frontal cortex. The increase in frontal cortical BDNF and activated TrkB at P60 occurred in male but not female mice. Thus, our data demonstrate that ongoing cocaine exposure produces a decrease in BDNF expression in the embryonic brain, and that prenatal cocaine exposure produces a sex-specific increase in frontal cortical BDNF-TrkB signaling at P60 only in male mice. Lastly, hyperacetylation of histone H3 at the Bdnf promoter is one epigenetic mechanism mediating the effects of prenatal cocaine exposure on Bdnf expression at P60 in male mice.

Journal Section:
Editor's choice
Keywords:
Cocaine, Brain-derived neurotrophic factor, Prenatal exposure, Tyrosine kinase B, Epigenetics
1.
Hedden SL, Kennet J, Lipari R, Medley G, Tice P, Copello EAP, Kroutil LA, Tice P, Hunter D: Behavioral health trends in the United States: results from the 2014 national survey on drug use and health. HHS Publication No. SMA 15-4927, NSDUH Series H-50. 2015. http://www.samhsa.gov/data/.
2.
Chae SM, Covington CY: Biobehavioral outcomes in adolescents and young adults prenatally exposed to cocaine: evidence from animal models. Biol Res Nurs 2009;10:318-330.
3.
Ayoola AB, Stommel M, Nettleman MD: Late recognition of pregnancy as a predictor of adverse birth outcomes. Am J Obstet Gynecol 2009;201:156.e1-e6.
4.
Skinner MK, Manikkam M, Guerrero-Bosagna C: Epigenetic transgenerational actions of endocrine disruptors. Reprod Toxicol 2011;31:337-343.
5.
Ackerman JP, Riggins T, Black MM: A review of the effects of prenatal cocaine exposure among school-aged children. Pediatrics 2010;125:554-565.
6.
Martin MM, Graham DL, McCarthy DM, Bhide PG, Stanwood GD: Cocaine-induced neurodevelopmental deficits and underlying mechanisms. Birth Defects Res C Embryo Today 2016;108:147-173.
7.
Akyuz N, Kekatpure MV, Liu J, Sheinkopf SJ, Quinn BT, Lala MD, Kennedy D, Makris N, Lester BM, Kosofsky BE: Structural brain imaging in children and adolescents following prenatal cocaine exposure: preliminary longitudinal findings. Dev Neurosci 2014;36:316-328.
8.
Bandstra ES, Morrow CE, Accornero VH, Mansoor E, Xue L, Anthony JC: Estimated effects of in utero cocaine exposure on language development through early adolescence. Neurotoxicol Teratol 2011;33:25-35.
9.
Liu J, Lester BM, Neyzi N, Sheinkopf SJ, Gracia L, Kekatpure M, Kosofsky BE: Regional brain morphometry and impulsivity in adolescents following prenatal exposure to cocaine and tobacco. JAMA Pediatr 2013;167:348-354.
10.
Sheinkopf SJ, Lester BM, Sanes JN, Eliassen JC, Hutchison ER, Seifer R, Lagasse LL, Durston S, Casey BJ: Functional MRI and response inhibition in children exposed to cocaine in utero: preliminary findings. Dev Neurosci 2009;31:159-166.
11.
Allen JW, Bennett DS, Carmody DP, Wang Y, Lewis M: Adolescent risk-taking as a function of prenatal cocaine exposure and biological sex. Neurotoxicol Teratol 2014;41:65-70.
12.
Carmody DP, Bennett DS, Lewis M: The effects of prenatal cocaine exposure and gender on inhibitory control and attention. Neurotoxicol Teratol 2011;33:61-68.
13.
Stucky A, Bakshi KP, Friedman E, Wang HY: Prenatal cocaine exposure upregulates BDNF-TrkB signaling. PLoS One 2016;11: e0160585.
14.
Kabir L, Katzman L, Rajadhyaksha A, Kosofsky BE: Brain derived neurotrophic factor genotype impacts the prenatal cocaine induced mouse phenotype. Dev Neurosci 2012;24:184-197.
15.
Kabir ZD, Katzman AC, Kosofsky BE: Molecular mechanisms mediating a deficit in recall of fear extinction in adult mice exposed to cocaine in utero. PLoS One 2013;8:e84165.
16.
Kabir ZD, Kennedy B, Katzman A, Lahvis GP, Kosofsky BE: Effects of prenatal cocaine exposure on social development in mice. Dev Neurosci 2014;36:338-346.
17.
Verheij MM, Vendruscolo LF, Caffino L, Giannotti G, Cazorla M, Fumagalli F, Riva MA, Homberg JR, Koob GF, Contet C: Systemic delivery of a brain-penetrant TrkB antagonist reduces cocaine self-administration and normalizes TrkB signaling in the nucleus accumbens and prefrontal cortex. J Neurosci 2016;36:8149-8159.
18.
McCarthy DM, Zhang X, Darnell SB, Sangrey GR, Yanagawa Y, Sadri-Vakili G, Bhide PG: Cocaine alters BDNF expression and neuronal migration in the embryonic mouse forebrain. J Neurosci 2011;31:13400-13411.
19.
McCarthy DM, Kabir ZD, Bhide PG, Kosofsky BE: Effects of prenatal exposure to cocaine on brain structure and function. Prog Brain Res 2014;211:277-289.
20.
McCarthy DM, Brown AN, Bhide PG: Regulation of BDNF expression by cocaine. Yale J Biol Med 2012;85:437-446.
21.
Shim SH, Hwangbo Y, Kwon YJ, Jeong HY, Lee BH, Lee HJ, Kim YK: Increased levels of plasma brain-derived neurotrophic factor (BDNF) in children with attention deficit- hyperactivity disorder (ADHD). Prog Neuropsychopharmacol Biol Psychiatry 2008;32:1824-1828.
22.
Tsai SJ: Attention-deficit hyperactivity disorder may be associated with decreased central brain-derived neurotrophic factor activity: clinical and therapeutic implications. Med Hypotheses 2007;68:896-899.
23.
Yeom CW, Park YJ, Choi SW, Bhang SY: Association of peripheral BDNF level with cognition, attention and behavior in preschool children. Child Adolesc Psychiatry Ment Health 2016;10:10.
24.
Corominas-Roso M, Ramos-Quiroga JA, Ribases M, Sanchez-Mora C, Palomar G, Valero S, Bosch R, Casas M: Decreased serum levels of brain-derived neurotrophic factor in adults with attention-deficit hyperactivity disorder. Int J Neuropsychopharmacol 2013;16:1267-1275.
25.
Ramos-Quiroga JA, Corominas-Roso M, Palomar G, Gomez-Barros N, Ribases M, Sanchez-Mora C, Bosch R, Nogueira M, Corrales M, Valero S, Casas M: Changes in the serum levels of brain-derived neurotrophic factor in adults with attention deficit hyperactivity disorder after treatment with atomoxetine. Psychopharmacology (Berlin) 2014;231:1389-1395.
26.
Fumagalli F, Di Pasquale L, Caffino L, Racagni G, Riva MA: Repeated exposure to cocaine differently modulates BDNF mRNA and protein levels in rat striatum and prefrontal cortex. Eur J Neurosci 2007;26:2756-2763.
27.
Fumagalli F, Caffino L, Racagni G, Riva MA: Repeated stress prevents cocaine-induced activation of BDNF signaling in rat prefrontal cortex. Eur Neuropsychopharmacol 2009;19:402-408.
28.
Berglind WJ, See RE, Fuchs RA, Ghee SM, Whitfield TW Jr, Miller SW, McGinty JF: A BDNF infusion into the medial prefrontal cortex suppresses cocaine seeking in rats. Eur J Neurosci 2007;26:757-766.
29.
Frith C, Dolan R: The role of the prefrontal cortex in higher cognitive functions. Brain Res Cogn Brain Res 1996;5:175-181.
30.
Wilkins AS, Genova LM, Posten W, Kosofsky BE: Transplacental cocaine exposure 1: a rodent model. Neurotoxicol Teratol 1998;20:215-226.
31.
Theiler K: The House Mouse: Development and Normal Stages of Fertilization to 4 Weeks of Age. Berlin, Springer, 1972.
32.
Kaufman MH: The Atlas of Mouse Development, ed 2. New York, Academic Press, 1992.
33.
Araki KY, Sims JR, Bhide PG: Dopamine receptor mRNA and protein expression in the mouse corpus striatum and cerebral cortex during pre- and postnatal development. Brain Res 2007;1156:31-45.
34.
Zhu J, Zhang X, Xu Y, Spencer TJ, Biederman J, Bhide PG: Prenatal nicotine exposure mouse model showing hyperactivity, reduced cingulate cortex volume, reduced dopamine turnover, and responsiveness to oral methylphenidate treatment. J Neurosci 2012;32:9410-9418.
35.
Zhang L, McCarthy DM, Sharma N, Bhide PG: Dopamine receptor and Gα(olf) expression in DYT1 dystonia mouse models during postnatal development. PLoS One 2015;10: e0123104.
36.
Sadri-Vakili G, Kumaresan V, Schmidt HD, Famous KR, Chawla P, Vassoler FM, Overland RP, Xia E, Bass CE, Terwilliger EF, Pierce RC, Cha JH: Cocaine-induced chromatin remodeling increases brain-derived neurotrophic factor transcription in the rat medial prefrontal cortex, which alters the reinforcing efficacy of cocaine. J Neurosci 2010;30:11735-11744.
37.
Vassoler FM, White SL, Schmidt HD, Sadri-Vakili G, Pierce RC: Epigenetic inheritance of a cocaine-resistance phenotype. Nat Neurosci 2013;16:42-47.
38.
Schmidt HD, Sangrey GR, Darnell SB, Schassburger RL, Cha JH, Pierce RC, Sadri-Vakili G: Increased brain-derived neurotrophic factor (BDNF) expression in the ventral tegmental area during cocaine abstinence is associated with increased histone acetylation at BDNF exon I-containing promoters. J Neurochem 2012;120:202-209.
39.
Aid T, Kazantseva A, Piirsoo M, Palm K, Timmusk T: Mouse and rat BDNF gene structure and expression revisited. J Neurosci Res 2007;85:525-535.
40.
Chen WG, Chang Q, Lin Y, Meissner A, West AE, Griffith EC, Jaenisch R, Greenberg ME: Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science 2003;302:885-889.
41.
Martinowich K, Hattori D, Wu H, Fouse S, He F, Hu Y, Fan G, Sun YE: DNA methylation-related chromatin remodeling in activity-dependent Bdnf gene regulation. Science 2003;302:890-893.
42.
McCarthy DM, Bell GA, Cannon EN, Mueller KA, Huizenga MN, Sadri-Vakili G, Fadool DA, Bhide PG: Reversal learning deficits associated with increased frontal cortical BDNF-TrkB signaling in a prenatal cocaine exposure mouse model. Dev Neurosci 2016, in press.
43.
Kaplan DR, Miller FD: Neurotrophin signal transduction in the nervous system. Curr Opin Neurobiol 2000;10:381-391.
44.
Huang EJ, Reichardt LF: Neurotrophins: roles in neuronal development and function. Ann Rev Neurosci 2001;24:677-736.
45.
Goggi J, Pullar IA, Carney SL, Bradford HF: Modulation of neurotransmitter release induced by brain-derived neurotrophic factor in rat brain striatal slices in vitro. Brain Res 2002;941:34-42.
46.
Martin-Iverson MT, Todd KG, Altar CA: Brain-derived neurotrophic factor and neurotrophin-3 activate striatal dopamine and serotonin metabolism and related behaviors: interactions with amphetamine. J Neurosci 1994;14:1262-1270.
47.
Kubrusly RC, Bhide PG: Cocaine exposure modulates dopamine and adenosine signaling in the fetal brain. Neuropharmacology 2010;58:436-443.
48.
Hill RA, van den Buuse M: Sex-dependent and region-specific changes in TrkB signaling in BDNF heterozygous mice. Brain Res 2011;1384:51-60.
49.
Monteggia LM, Luikart B, Barrot M, Theobold D, Malkovska I, Nef S, Parada LF, Nestler EJ: Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors. Biol Psychiatry 2007;61:187-197.
50.
Wu YC, Hill RA, Gogos A, van den Buuse M: Sex differences and the role of estrogen in animal models of schizophrenia: interaction with BDNF. Neuroscience 2013;239:67-83.
51.
Liu B, Xie JX: Recent progresses on the modulation of estrogen to dopaminergic neurons (in Chinese). Sheng Li Ke Xue Jin Zhan 2001;32:259-261.
52.
Harte-Hargrove LC, Maclusky NJ, Scharfman HE: Brain-derived neurotrophic factor-estrogen interactions in the hippocampal mossy fiber pathway: implications for normal brain function and disease. Neuroscience 2013;239:46-66.
53.
Miranda RC, Sohrabji F, Toran-Allerand CD: Presumptive estrogen target neurons express mRNAs for both the neurotrophins and neurotrophin receptors: a basis for potential developmental interactions of estrogen with the neurotrophins. Mol Cell Neurosci 1993;4:510-525.
54.
Nugent BM, McCarthy MM: Epigenetic underpinnings of developmental sex differences in the brain. Neuroendocrinology 2011;93:150-158.
55.
Crandall JE, Hackett HE, Tobet SA, Kosofsky BE, Bhide PG: Cocaine exposure decreases GABA neuron migration from the ganglionic eminence to the cerebral cortex in embryonic mice. Cereb Cortex 2004;14:665-675.
56.
Wilkins AS, Marota JJ, Tabit E, Kosofsky BE: Transplacental cocaine exposure 3: mechanisms underlying altered brain development. Neurotoxicol Teratol 1998;20:239-249.
57.
Toledo-Rodriguez M, Lotfipour S, Leonard G, Perron M, Richer L, Veillette S, Pausova Z, Paus T: Maternal smoking during pregnancy is associated with epigenetic modifications of the brain-derived neurotrophic factor-6 exon in adolescent offspring. Am J Med Genet B Neuropsychiatr Genet 2010;153B:1350-1354.
58.
Terry MB, Ferris JS, Pilsner R, Flom JD, Tehranifar P, Santella RM, Gamble MV, Susser E: Genomic DNA methylation among women in a multiethnic New York City birth cohort. Cancer Epidemiol Biomarkers Prev 2008;17:2306-2310.
59.
Wei J, Wang J, Dwyer JB, Mangold J, Cao J, Leslie FM, Li MD: Gestational nicotine treatment modulates cell death/survival-related pathways in the brains of adolescent female rats. Int J Neuropsychopharmacol 2011;14:91-106.
60.
Lacy RT, Brown RW, Morgan AJ, Mactutus CF, Harrod SB: Intravenous prenatal nicotine exposure alters meth-induced hyperactivity, conditioned hyperactivity, and BDNF in adult rat offspring. Dev Neurosci 2016;38:171-185.
61.
Harrod SB, Lacy RT, Zhu J, Hughes BA, Perna MK, Brown RW: Gestational IV nicotine produces elevated brain-derived neurotrophic factor in the mesocorticolimbic dopamine system of adolescent rat offspring. Synapse 2011;65:1382-1392.
62.
Yochum C, Doherty-Lyon S, Hoffman C, Hossain MM, Zelikoff JT, Richardson JR: Prenatal cigarette smoke exposure causes hyperactivity and aggressive behavior: role of altered catecholamines and BDNF. Exp Neurol 2014;254:145-152.
63.
Dong E, Ruzicka WB, Grayson DR, Guidotti A: DNA-methyltransferase1 (DNMT1) binding to CpG rich GABAergic and BDNF promoters is increased in the brain of schizophrenia and bipolar disorder patients. Schizophr Res 2015;167:35-41.
© 2017 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2017
You do not currently have access to this content.